Clinical Potential of YY1-Hypoxia Axis for Vascular Normalization and to Improve Immunotherapy
Abnormal vasculature in solid tumors causes poor blood perfusion, hypoxia, low pH, and immune evasion. It also shapes the tumor microenvironment and affects response to immunotherapy. The combination of antiangiogenic therapy and immunotherapy has emerged as a promising approach to normalize vascula...
Main Authors: | Concetta Meo, Filomena de Nigris |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/16/3/491 |
Similar Items
-
Towards Immunotherapy-Induced Normalization of the Tumor Microenvironment
by: Vinicio Melo, et al.
Published: (2022-05-01) -
Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy
by: Bin Wang, et al.
Published: (2021-01-01) -
Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
by: S. K. Daniel, et al.
Published: (2019-04-01) -
Targeting vascular normalization: a promising strategy to improve immune–vascular crosstalk in cancer immunotherapy
by: Cheng Qian, et al.
Published: (2023-12-01) -
The Effect of Hypoxia-Induced Exosomes on Anti-Tumor Immunity and Its Implication for Immunotherapy
by: Wenwen Guo, et al.
Published: (2022-06-01)